APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Precision Medicine

According to the National Institutes of Health (NIH), precision medicine is "an emerging approach for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle for each person." This approach will allow doctors and researchers to predict more accurately which treatment and prevention strategies for a particular disease will work in which groups of people. It is in contrast to a "one-size-fits-all" approach, in which disease treatment and prevention strategies are developed for the average person, with less consideration for the differences between individuals.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

According to the National Institutes of Health (NIH), precision medicine is "an emerging approach for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle for each person." This approach will allow doctors and researchers to predict more accurately which treatment and prevention strategies for a particular disease will work in which groups of people. It is in contrast to a "one-size-fits-all" approach, in which disease treatment and prevention strategies are developed for the average person, with less consideration for the differences between individuals.

Although the term "precision medicine" is relatively new, the concept has been a part of healthcare for many years. For example, a person who needs a blood transfusion is not given blood from a randomly selected donor; instead, the donor’s blood type is matched to the recipient to reduce the risk of complications. Although examples can be found in several areas of medicine, the role of precision medicine in day-to-day healthcare is relatively limited. Researchers hope that this approach will expand to many areas of health in coming years.

Selected research

Market Outlook & Growth Opportunities

Global Precision Medicine Market Outlook and Growth Opportunities 2026

Report ID 173895310425 December 2025208 pages

Choose your research edition.

Industry ResearchPrecision Medicine Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Precision Medicine Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Precision Medicine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Precision Medicine Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Precision Medicine Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

According to the National Institutes of Health (NIH), precision medicine is "an emerging approach for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle for each person." This approach will allow doctors and researchers to predict more accurately which treatment and prevention strategies for a particular disease will work in which groups of people. It is in contrast to a "one-size-fits-all" approach, in which disease treatment and prevention strategies are developed for the average person, with less consideration for the differences between individuals.

Although the term "precision medicine" is relatively new, the concept has been a part of healthcare for many years. For example, a person who needs a blood transfusion is not given blood from a randomly selected donor; instead, the donor’s blood type is matched to the recipient to reduce the risk of complications. Although examples can be found in several areas of medicine, the role of precision medicine in day-to-day healthcare is relatively limited. Researchers hope that this approach will expand to many areas of health in coming years.

The classification of precision medicine includes diagnostics and therapies, and the proportion of diagnostics is about 67%.

Read the full market overview

Precision Medicine is used for oncology, neurosciences, immunology, respiratory and other field. The most proportion of precision medicine is for oncology, and the market share is about 30%.

Market competition is intense. Johnson & Johnson, Roche, Labcorp, Abbott Laboratories and Novartis are the leaders of the industry, with about 56% market shares.

This report provides an overview of the global Precision Medicine market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Precision Medicine and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Precision Medicine revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Precision Medicine market.

Precision Medicine Segment by Company

Johnson & Johnson

Roche

Labcorp

Abbott Laboratories

Novartis

Illumina

GE Healthcare

Intel Corporation

Biomrieux Sa

Cepheid

IBM

Qiagen

Thermo Fisher Scientific

Randox Laboratories

Almac Group

Healthcore

Precision Medicine Segment by Type

Diagnostics

Therapies

Precision Medicine Segment by Application

Oncology

Neurosciences

Immunology

Respiratory

Others

Precision Medicine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Precision Medicine status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Precision Medicine key companies, revenue, market share, and recent developments.

3. To split the Precision Medicine breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Precision Medicine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Precision Medicine significant trends, drivers, influence factors in global and regions.

6. To analyze Precision Medicine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Precision Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Precision Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Precision Medicine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Precision Medicine industry.

Chapter 3: Detailed analysis of Precision Medicine company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Precision Medicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Precision Medicine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Precision Medicine Industry Trends Table 2. Precision Medicine Industry Drivers Table 3. Precision Medicine Industry Opportunities and Challenges Table 4. Precision Medicine Industry Restraints Table 5. Global Precision Medicine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Precision Medicine Revenue Share by Company (2021-2026) Table 7. Global Precision Medicine Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Precision Medicine Key Company Manufacturing Base & Headquarters Table 9. Global Precision Medicine Company, Product Type & Application Table 10. Global Precision Medicine Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Precision Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Diagnostics Table 15. Significant Companies of Therapies Table 16. Global Precision Medicine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Precision Medicine Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Precision Medicine Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Precision Medicine Sales Value Share by Type (2021-2026) Table 20. Global Precision Medicine Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Oncology Table 22. Significant Companies of Neurosciences Table 23. Significant Companies of Immunology Table 24. Significant Companies of Respiratory Table 25. Significant Companies of Others Table 26. Global Precision Medicine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Precision Medicine Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Precision Medicine Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Precision Medicine Sales Value Share by Application (2021-2026) Table 30. Global Precision Medicine Sales Value Share by Application (2027-2032) Table 31. Global Precision Medicine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Precision Medicine Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Precision Medicine Sales Value Share by Region (2021-2026) Table 34. Global Precision Medicine Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Precision Medicine Sales Value Share by Region (2027-2032) Table 36. Global Precision Medicine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Precision Medicine Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Precision Medicine Sales Value Market Share by Country (2021-2026) Table 39. Global Precision Medicine Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Precision Medicine Sales Value Market Share by Country (2027-2032) Table 41. Johnson & Johnson Company Information Table 42. Johnson & Johnson Business Overview Table 43. Johnson & Johnson Precision Medicine Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Johnson & Johnson Precision Medicine Product Portfolio Table 45. Johnson & Johnson Recent Development Table 46. Roche Company Information Table 47. Roche Business Overview Table 48. Roche Precision Medicine Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Roche Precision Medicine Product Portfolio Table 50. Roche Recent Development Table 51. Labcorp Company Information Table 52. Labcorp Business Overview Table 53. Labcorp Precision Medicine Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Labcorp Precision Medicine Product Portfolio Table 55. Labcorp Recent Development Table 56. Abbott Laboratories Company Information Table 57. Abbott Laboratories Business Overview Table 58. Abbott Laboratories Precision Medicine Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Abbott Laboratories Precision Medicine Product Portfolio Table 60. Abbott Laboratories Recent Development Table 61. Novartis Company Information Table 62. Novartis Business Overview Table 63. Novartis Precision Medicine Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Novartis Precision Medicine Product Portfolio Table 65. Novartis Recent Development Table 66. Illumina Company Information Table 67. Illumina Business Overview Table 68. Illumina Precision Medicine Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Illumina Precision Medicine Product Portfolio Table 70. Illumina Recent Development Table 71. GE Healthcare Company Information Table 72. GE Healthcare Business Overview Table 73. GE Healthcare Precision Medicine Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. GE Healthcare Precision Medicine Product Portfolio Table 75. GE Healthcare Recent Development Table 76. Intel Corporation Company Information Table 77. Intel Corporation Business Overview Table 78. Intel Corporation Precision Medicine Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Intel Corporation Precision Medicine Product Portfolio Table 80. Intel Corporation Recent Development Table 81. Biomrieux Sa Company Information Table 82. Biomrieux Sa Business Overview Table 83. Biomrieux Sa Precision Medicine Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Biomrieux Sa Precision Medicine Product Portfolio Table 85. Biomrieux Sa Recent Development Table 86. Cepheid Company Information Table 87. Cepheid Business Overview Table 88. Cepheid Precision Medicine Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Cepheid Precision Medicine Product Portfolio Table 90. Cepheid Recent Development Table 91. IBM Company Information Table 92. IBM Business Overview Table 93. IBM Precision Medicine Sales (), Value (US$ Million), Price () and Gross Margin (2021-2026) Table 94. IBM Precision Medicine Product Portfolio Table 95. IBM Recent Development Table 96. Qiagen Company Information Table 97. Qiagen Business Overview Table 98. Qiagen Precision Medicine Sales (), Value (US$ Million), Price () and Gross Margin (2021-2026) Table 99. Qiagen Precision Medicine Product Portfolio Table 100. Qiagen Recent Development Table 101. Thermo Fisher Scientific Company Information Table 102. Thermo Fisher Scientific Business Overview Table 103. Thermo Fisher Scientific Precision Medicine Sales (), Value (US$ Million), Price () and Gross Margin (2021-2026) Table 104. Thermo Fisher Scientific Precision Medicine Product Portfolio Table 105. Thermo Fisher Scientific Recent Development Table 106. Randox Laboratories Company Information Table 107. Randox Laboratories Business Overview Table 108. Randox Laboratories Precision Medicine Sales (), Value (US$ Million), Price () and Gross Margin (2021-2026) Table 109. Randox Laboratories Precision Medicine Product Portfolio Table 110. Randox Laboratories Recent Development Table 111. Almac Group Company Information Table 112. Almac Group Business Overview Table 113. Almac Group Precision Medicine Sales (), Value (US$ Million), Price () and Gross Margin (2021-2026) Table 114. Almac Group Precision Medicine Product Portfolio Table 115. Almac Group Recent Development Table 116. Healthcore Company Information Table 117. Healthcore Business Overview Table 118. Healthcore Precision Medicine Sales (), Value (US$ Million), Price () and Gross Margin (2021-2026) Table 119. Healthcore Precision Medicine Product Portfolio Table 120. Healthcore Recent Development Table 121. Research Programs/Design for This Report Table 122. Authors List of This Report Table 123. Secondary Sources Table 124. Primary Sources List of Figures Figure 1. Precision Medicine Product Image Figure 2. Global Precision Medicine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Precision Medicine Market Size (2021-2032) & (US$ Million) Figure 4. Global Precision Medicine Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Diagnostics Image Figure 8. Therapies Image Figure 9. Global Precision Medicine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Precision Medicine Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Precision Medicine Sales Value Share by Type (2021-2032) Figure 12. Oncology Image Figure 13. Neurosciences Image Figure 14. Immunology Image Figure 15. Respiratory Image Figure 16. Others Image Figure 17. Global Precision Medicine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Precision Medicine Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Precision Medicine Sales Value Share by Application (2021-2032) Figure 20. Global Precision Medicine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Precision Medicine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Precision Medicine Sales Value (2021-2032) & (US$ Million) Figure 23. North America Precision Medicine Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Precision Medicine Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Precision Medicine Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Precision Medicine Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Precision Medicine Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Precision Medicine Sales Value (2021-2032) & (US$ Million) Figure 29. South America Precision Medicine Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Precision Medicine Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Precision Medicine Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Precision Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Precision Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Precision Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Precision Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Precision Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Precision Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Precision Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Precision Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Precision Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Precision Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Precision Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Precision Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Precision Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Precision Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Precision Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Precision Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Precision Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Precision Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Precision Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Precision Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Precision Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Precision Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Precision Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Precision Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Precision Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Precision Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Precision Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Precision Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Precision Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Precision Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Precision Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Precision Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Precision Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Precision Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Precision Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Precision Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Precision Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Precision Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Precision Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Precision Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Precision Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Precision Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Precision Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Precision Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Precision Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Precision Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Precision Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Precision Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Precision Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Precision Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Precision Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Precision Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Precision Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Precision Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Precision Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Precision Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Precision Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Precision Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Precision Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Precision Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Precision Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Precision Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Precision Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Precision Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Precision Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Precision Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Precision Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Precision Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Precision Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Precision Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Precision Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Precision Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Precision Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Precision Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Precision Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Precision Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Precision Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Precision Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Precision Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Precision Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Precision Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Precision Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Precision Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Precision Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Diagnostics
  • Therapies
Applications
  • Oncology
  • Neurosciences
  • Immunology
  • Respiratory
  • Others
Companies covered
  • Johnson & Johnson
  • Roche
  • Labcorp
  • Abbott Laboratories
  • Novartis
  • Illumina
  • GE Healthcare
  • Intel Corporation
  • Biomrieux Sa
  • Cepheid
  • IBM
  • Qiagen
  • Thermo Fisher Scientific
  • Randox Laboratories
  • Almac Group
  • Healthcore

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Precision Medicine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Precision Medicine Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Precision Medicine Market Dynamics
  1. 2.1 Precision Medicine Industry Trends
  2. 2.2 Precision Medicine Industry Drivers
  3. 2.3 Precision Medicine Industry Opportunities and Challenges
  4. 2.4 Precision Medicine Industry Restraints
3 Precision Medicine Market by Company
  1. 3.1 Global Precision Medicine Company Revenue Ranking in 2025
  2. 3.2 Global Precision Medicine Revenue by Company (2021-2026)
  3. 3.3 Global Precision Medicine Company Ranking (2024-2026)
  4. 3.4 Global Precision Medicine Company Manufacturing Base and Headquarters
  5. 3.5 Global Precision Medicine Company Product Type and Application
  6. 3.6 Global Precision Medicine Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Precision Medicine Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Precision Medicine Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Precision Medicine Market by Type
  1. 4.1 Precision Medicine Type Introduction
  2. 4.1.1 Diagnostics
  3. 4.1.2 Therapies
  4. 4.2 Global Precision Medicine Sales Value by Type
  5. 4.2.1 Global Precision Medicine Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Precision Medicine Sales Value by Type (2021-2032)
  7. 4.2.3 Global Precision Medicine Sales Value Share by Type (2021-2032)
5 Precision Medicine Market by Application
  1. 5.1 Precision Medicine Application Introduction
  2. 5.1.1 Oncology
  3. 5.1.2 Neurosciences
  4. 5.1.3 Immunology
  5. 5.1.4 Respiratory
  6. 5.1.5 Others
  7. 5.2 Global Precision Medicine Sales Value by Application
  8. 5.2.1 Global Precision Medicine Sales Value by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Precision Medicine Sales Value by Application (2021-2032)
  10. 5.2.3 Global Precision Medicine Sales Value Share by Application (2021-2032)
6 Precision Medicine Regional Value Analysis
  1. 6.1 Global Precision Medicine Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Precision Medicine Sales Value by Region (2021-2032)
  3. 6.2.1 Global Precision Medicine Sales Value by Region: 2021-2026
  4. 6.2.2 Global Precision Medicine Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Precision Medicine Sales Value (2021-2032)
  7. 6.3.2 North America Precision Medicine Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Precision Medicine Sales Value (2021-2032)
  10. 6.4.2 Europe Precision Medicine Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Precision Medicine Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Precision Medicine Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Precision Medicine Sales Value (2021-2032)
  16. 6.6.2 South America Precision Medicine Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Precision Medicine Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Precision Medicine Sales Value Share by Country, 2025 VS 2032
7 Precision Medicine Country-level Value Analysis
  1. 7.1 Global Precision Medicine Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Precision Medicine Sales Value by Country (2021-2032)
  3. 7.2.1 Global Precision Medicine Sales Value by Country (2021-2026)
  4. 7.2.2 Global Precision Medicine Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Precision Medicine Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Precision Medicine Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Precision Medicine Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Precision Medicine Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Precision Medicine Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Precision Medicine Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Precision Medicine Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Precision Medicine Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Precision Medicine Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Precision Medicine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Precision Medicine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Precision Medicine Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Precision Medicine Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Precision Medicine Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Precision Medicine Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Precision Medicine Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Precision Medicine Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Precision Medicine Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Precision Medicine Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Precision Medicine Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Precision Medicine Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Precision Medicine Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Precision Medicine Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Precision Medicine Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Precision Medicine Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Precision Medicine Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Precision Medicine Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Precision Medicine Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Precision Medicine Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Precision Medicine Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Precision Medicine Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Precision Medicine Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Precision Medicine Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Precision Medicine Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Precision Medicine Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Precision Medicine Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Precision Medicine Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Precision Medicine Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Precision Medicine Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Precision Medicine Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Precision Medicine Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Precision Medicine Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Precision Medicine Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Precision Medicine Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Precision Medicine Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Precision Medicine Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Precision Medicine Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Precision Medicine Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Precision Medicine Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Precision Medicine Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Precision Medicine Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Precision Medicine Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Precision Medicine Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Precision Medicine Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Precision Medicine Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Precision Medicine Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Precision Medicine Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Precision Medicine Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Precision Medicine Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Precision Medicine Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Precision Medicine Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Precision Medicine Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Precision Medicine Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Precision Medicine Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Precision Medicine Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Precision Medicine Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Precision Medicine Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Precision Medicine Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Precision Medicine Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Precision Medicine Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Precision Medicine Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Precision Medicine Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Precision Medicine Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Precision Medicine Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Precision Medicine Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Precision Medicine Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Precision Medicine Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Precision Medicine Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Precision Medicine Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Precision Medicine Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Precision Medicine Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Precision Medicine Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Precision Medicine Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Precision Medicine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Johnson & Johnson
  2. 8.1.1 Johnson & Johnson Company Information
  3. 8.1.2 Johnson & Johnson Business Overview
  4. 8.1.3 Johnson & Johnson Precision Medicine Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Johnson & Johnson Precision Medicine Product Portfolio
  6. 8.1.5 Johnson & Johnson Recent Developments
  7. 8.2 Roche
  8. 8.2.1 Roche Company Information
  9. 8.2.2 Roche Business Overview
  10. 8.2.3 Roche Precision Medicine Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Roche Precision Medicine Product Portfolio
  12. 8.2.5 Roche Recent Developments
  13. 8.3 Labcorp
  14. 8.3.1 Labcorp Company Information
  15. 8.3.2 Labcorp Business Overview
  16. 8.3.3 Labcorp Precision Medicine Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Labcorp Precision Medicine Product Portfolio
  18. 8.3.5 Labcorp Recent Developments
  19. 8.4 Abbott Laboratories
  20. 8.4.1 Abbott Laboratories Company Information
  21. 8.4.2 Abbott Laboratories Business Overview
  22. 8.4.3 Abbott Laboratories Precision Medicine Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Abbott Laboratories Precision Medicine Product Portfolio
  24. 8.4.5 Abbott Laboratories Recent Developments
  25. 8.5 Novartis
  26. 8.5.1 Novartis Company Information
  27. 8.5.2 Novartis Business Overview
  28. 8.5.3 Novartis Precision Medicine Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Novartis Precision Medicine Product Portfolio
  30. 8.5.5 Novartis Recent Developments
  31. 8.6 Illumina
  32. 8.6.1 Illumina Company Information
  33. 8.6.2 Illumina Business Overview
  34. 8.6.3 Illumina Precision Medicine Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Illumina Precision Medicine Product Portfolio
  36. 8.6.5 Illumina Recent Developments
  37. 8.7 GE Healthcare
  38. 8.7.1 GE Healthcare Company Information
  39. 8.7.2 GE Healthcare Business Overview
  40. 8.7.3 GE Healthcare Precision Medicine Revenue and Gross Margin (2021-2026)
  41. 8.7.4 GE Healthcare Precision Medicine Product Portfolio
  42. 8.7.5 GE Healthcare Recent Developments
  43. 8.8 Intel Corporation
  44. 8.8.1 Intel Corporation Company Information
  45. 8.8.2 Intel Corporation Business Overview
  46. 8.8.3 Intel Corporation Precision Medicine Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Intel Corporation Precision Medicine Product Portfolio
  48. 8.8.5 Intel Corporation Recent Developments
  49. 8.9 Biomrieux Sa
  50. 8.9.1 Biomrieux Sa Company Information
  51. 8.9.2 Biomrieux Sa Business Overview
  52. 8.9.3 Biomrieux Sa Precision Medicine Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Biomrieux Sa Precision Medicine Product Portfolio
  54. 8.9.5 Biomrieux Sa Recent Developments
  55. 8.10 Cepheid
  56. 8.10.1 Cepheid Company Information
  57. 8.10.2 Cepheid Business Overview
  58. 8.10.3 Cepheid Precision Medicine Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Cepheid Precision Medicine Product Portfolio
  60. 8.10.5 Cepheid Recent Developments
  61. 8.11 IBM
  62. 8.11.1 IBM Company Information
  63. 8.11.2 IBM Business Overview
  64. 8.11.3 IBM Precision Medicine Revenue and Gross Margin (2021-2026)
  65. 8.11.4 IBM Precision Medicine Product Portfolio
  66. 8.11.5 IBM Recent Developments
  67. 8.12 Qiagen
  68. 8.12.1 Qiagen Company Information
  69. 8.12.2 Qiagen Business Overview
  70. 8.12.3 Qiagen Precision Medicine Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Qiagen Precision Medicine Product Portfolio
  72. 8.12.5 Qiagen Recent Developments
  73. 8.13 Thermo Fisher Scientific
  74. 8.13.1 Thermo Fisher Scientific Company Information
  75. 8.13.2 Thermo Fisher Scientific Business Overview
  76. 8.13.3 Thermo Fisher Scientific Precision Medicine Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Thermo Fisher Scientific Precision Medicine Product Portfolio
  78. 8.13.5 Thermo Fisher Scientific Recent Developments
  79. 8.14 Randox Laboratories
  80. 8.14.1 Randox Laboratories Company Information
  81. 8.14.2 Randox Laboratories Business Overview
  82. 8.14.3 Randox Laboratories Precision Medicine Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Randox Laboratories Precision Medicine Product Portfolio
  84. 8.14.5 Randox Laboratories Recent Developments
  85. 8.15 Almac Group
  86. 8.15.1 Almac Group Company Information
  87. 8.15.2 Almac Group Business Overview
  88. 8.15.3 Almac Group Precision Medicine Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Almac Group Precision Medicine Product Portfolio
  90. 8.15.5 Almac Group Recent Developments
  91. 8.16 Healthcore
  92. 8.16.1 Healthcore Company Information
  93. 8.16.2 Healthcore Business Overview
  94. 8.16.3 Healthcore Precision Medicine Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Healthcore Precision Medicine Product Portfolio
  96. 8.16.5 Healthcore Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst